Results 261 to 270 of about 224,309 (314)

Laparoscopy in the Management of Peritoneal Carcinomatosis

The Cancer Journal, 2009
The use of videolaparoscopy in the assessment of peritoneal carcinomatosis extent is now universally accepted. This procedure allows us to define with certainty the origin of the neoplasm, the peritoneal cancer index (PCI), the involvement of the small bowel and its mesentery, the feasibility of surgery and the index of attainable cytoreduction, the ...
Mario Valle, Alfredo Garofalo
openaire   +3 more sources

Colorectal cancer and peritoneal carcinomatosis

Seminars in Surgical Oncology, 1996
Colorectal cancer ranks third in new cancer cases and in cancer deaths in men and women combined in the United States. Additionally, the probability of developing an invasive colorectal cancer over one's life-time is around 1 in 16. This amounts to approximately 133,000 new cancer cases and 55,000 cancer deaths yearly.
Russell K. Pearl, Jose R. Cintron
openaire   +3 more sources

CT manifestations of peritoneal carcinomatosis

American Journal of Roentgenology, 1988
Seventy-three abdominopelvic contrast-enhanced CT scans obtained in 60 patients with peritoneal tumor spread were reviewed retrospectively to determine the CT signs of peritoneal malignancy. Ascites was present in 54 studies (74%) and was the most common CT finding. Loculation of the fluid occurred in 25 (46%) of these.
Arnold C. Friedman, MM Walkey, P D Radecki, P Sohotra   +3 more
openaire   +3 more sources

Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

Journal of Clinical Oncology, 2003
PURPOSE To confirm the findings from uncontrolled studies that aggressive cytoreduction in combination with hyperthermic intraperitoneal chemotherapy (HIPEC) is superior to standard treatment in patients with peritoneal carcinomatosis of colorectal ...
V. Verwaal, S. van Ruth, E. de Bree, Gooike W van Sloothen, H. van Tinteren, H. Boot, F. Zoetmulder   +6 more
semanticscholar   +1 more source

Surgery for colorectal peritoneal carcinomatosis

Scandinavian Journal of Gastroenterology, 2012
Peritoneal carcinomatosis occurs in patients with advanced gastrointestinal and gynecological malignancies and also in patients who experience recurrence after treatment failure of the primary tumor. Malignant disease in the peritoneal cavity is a morbid and significant predictor of a diminished survival in a cancer patient. Systemic chemotherapy alone
David L. Morris, Terence C. Chua, Joerg O.W. Pelz   +2 more
openaire   +3 more sources

Signet ring cell features with peritoneal carcinomatosis in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are associated with poor overall survival

Journal of Surgical Oncology, 2019
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is effective in select patients with peritoneal carcinomatosis (PC). Signet ring cell (SRC) pathology is associated with poor prognosis.
D. Solomon, Natasha DeNicola, D. Feingold, Peter H. Liu, Samantha N. Aycart, B. Golas, U. Sarpel, D. Labow, D. Magge   +8 more
semanticscholar   +1 more source

Peritoneal carcinomatosis in refractory seminoma

International Journal of Urology, 2004
Abstract Intraperitoneal metastasis from a testicular germ cell tumor is very rare. We report a case in a 33‐year‐old man who was referred to Hokkaido University Hospital, Hokkaido, Japan, for further therapy for refractory seminoma. Physical examination revealed abdominal distension as a result of ascites, and cytology of the ascites showed seminoma ...
Nobuo Shinohara, Tomohiko Koyanagi, Toshimori Seki, Kunihiko Tsuchiya, Tohru Harabayashi, Takashige Abe, Masaki Togashi, Shin Suzuki, Tomoo Itoh, Katsuya Nonomura   +9 more
openaire   +3 more sources

Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic Options

Neuroendocrinology, 2019
Background: Peritoneal carcinomatosis (PC) can affect the quality of life of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs).
E. Merola, V. Prasad, A. Pascher, U. Pape, R. Arsenić, T. Denecke, U. Fehrenbach, B. Wiedenmann, M. Pavel   +8 more
semanticscholar   +1 more source

Peritoneal carcinomatosis in lung cancer

Respirology, 2008
Background and objective:  A survey was carried out of peritoneal carcinomatosis (PC) in lung cancer.Methods:  A retrospective analysis was conducted of all lung cancer patients with malignant ascites diagnosed between 1990 and 2005 at a general hospital in Taiwan.Results:  There were 30 lung cancer patients with documented PC.
Hsuan-Tsung Su, Reury-Perng Perng, Reury-Perng Perng, Chun-Ming Tsai, Chun-Ming Tsai   +4 more
openaire   +3 more sources

Peritoneal carcinomatosis of colorectal origin

Gastroentérologie Clinique et Biologique, 2006
Complete resection of macroscopic colorectal peritoneal carcinomatosis (PC), followed by intraoperative intraperitoneal chemohyperthermia (IPCH) to treat residual microscopic disease achieves cure in some patients. We report long-term results concerning survival of a phase II study using oxaliplatin (LOHP).From June 1998 to December 2003, thirty ...
Diane Goéré, Delphine Rouquie, Raoul Ciuchendea, Michel Ducreux, Dominique Elias, Ferechte Farkhondeh, Marc Pocard, Bruno Raynard   +7 more
openaire   +3 more sources